Veterinary Immunology and Immunopathology

When infected with Trypanosoma cruzi, Beagle dogs develop symptoms similar to those of Chagas disease in human beings, and could be an important experimental model for a better understanding of the immunopathogenic mechanisms involved in chronic chagasic infection. This study evaluates IL-10, IFN-g and TNF-a production in the sera, culture supernatant, heart and cervical lymph nodes and their correlation with cardiomegaly, cardiac inflammation and fibrosis in Beagle dogs infected with T. cruzi. Pathological analysis showed severe splenomegaly, lymphadenopathy and myocarditis in all infected dogs during the acute phase of the disease, with cardiomegaly, inflammation and fibrosis observed in 83% of the animals infected by T. cruzi during the chronic phase. The data indicate that infected animals producing IL-10 in the heart during the chronic phase and showing high IL-10 production in the culture supernatant and serum during the acute phase had lower cardiac alterations (myocarditis, fibrosis and cardiomegaly) than those with high IFN-g and TNF-a levels. These animals produced low IL-10 levels in the culture supernatant and serum during the acute phase and did not produce IL-10 in the heart during the chronic phase of the disease. Our findings showed that Beagle dogs are a good model for studying the immunopathogenic mechanism of Chagas disease, since they reproduce the clinical and immunological findings described in chagasic patients. The data suggest that the development of the chronic cardiac form of the disease is related to a strong Th1 response during the acute phase of the disease, while the development of the indeterminate form results from a blend of Th1 and Th2 responses soon after infection, suggesting that the acute phase immune response is important for the genesis of chronic

[1]  W. J. Langford Statistical Methods , 1959, Nature.

[2]  W. Tafuri [Pathogenesis of Chagas' disease]. , 1987, Revista do Instituto de Medicina Tropical de Sao Paulo.

[3]  C. Carneiro,et al.  Quantitative analysis of cardiac lesions in chronic canine chagasic cardiomyopathy. , 2002, Revista do Instituto de Medicina Tropical de Sao Paulo.

[4]  R. Coffman,et al.  IFN-gamma in human Chagas' disease: protection or pathology? , 1998, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[5]  F. Brombacher,et al.  Defective Nitric Oxide Effector Functions Lead to Extreme Susceptibility of Trypanosoma cruzi-Infected Mice Deficient in Gamma Interferon Receptor or Inducible Nitric Oxide Synthase , 1998, Infection and Immunity.

[6]  S. Ekşi,et al.  Host genetics and resistance to acute Trypanosoma cruzi infection in mice: profiles and compartmentalization of IL-2-, -4-, -5-, -10-, and IFN-gamma-producing cells. , 1996, The Journal of parasitology.

[7]  Lei Zhang,et al.  Characterization of cytokine production in murine Trypanosoma cruzi infection by in situ immunocytochemistry: Lack of association between susceptibility and type 2 cytokine production , 1996, European journal of immunology.

[8]  M. Elizari,et al.  Cardiac Arrhythmias in Chagas’Heart Disease , 1993, Journal of cardiovascular electrophysiology.

[9]  L. Guilherme,et al.  Cytokine production profile of heart-infiltrating T cells in Chagas' disease cardiomyopathy. , 1998, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[10]  G. Menezes,et al.  Vascular and cellular responses to pro-inflammatory stimuli in rat dental pulp. , 2004, Archives of oral biology.

[11]  M. Lana,et al.  [Comparative biological characterization of Berenice and Berenice-78 strains of Trypanosoma cruzi isolated from the same patient at different times]. , 1986, Memorias do Instituto Oswaldo Cruz.

[12]  F. Pileggi,et al.  Association of an increase in CD8+ T cells with the presence of Trypanosoma cruzi antigens in chronic, human, chagasic myocarditis. , 1997, The American journal of tropical medicine and hygiene.

[13]  C. Carneiro,et al.  Trypanosoma cruzi high infectivity in vitro is related to cardiac lesions during long-term infection in Beagle dogs. , 2007, Memorias do Instituto Oswaldo Cruz.

[14]  W. Tafuri Pathogenesis of lesions of the autonomic nervous system of the mouse in experimental acute Chagas' disease. Light and electron microscope studies. , 1970, The American journal of tropical medicine and hygiene.

[15]  C. Mady,et al.  The monocyte chemoattractant protein-1 gene polymorphism is associated with cardiomyopathy in human chagas disease. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  C. Carneiro,et al.  Comparison of Trypanosoma cruzi infection in dogs inoculated with blood or metacyclic trypomastigotes of Berenice-62 and Berenice-78 strains via intraperitoneal and conjunctival routes. , 2002, Revista da Sociedade Brasileira de Medicina Tropical.

[17]  C. Carneiro,et al.  Variation in susceptibility to benznidazole in isolates derived from Trypanosoma cruzi parental strains. , 2001, Memorias do Instituto Oswaldo Cruz.

[18]  F. Pileggi,et al.  Right ventricular endomyocardial biopsy in chronic Chagas' disease. , 1986, American heart journal.

[19]  R. Corrêa-Oliveira,et al.  The role of the immune response on the development of severe clinical forms of human Chagas disease. , 1999, Memorias do Instituto Oswaldo Cruz.

[20]  E. Chiari,et al.  Experimental Chagas' disease in dogs. , 1992, Memorias do Instituto Oswaldo Cruz.

[21]  L. Rénia,et al.  Chagasic patients develop a type 1 immune response to Trypanosoma cruzi trans‐sialidase , 2000, Parasite immunology.

[22]  M. Higuchi Chronic chagasic cardiopathy: the product of a turbulent host-parasite relationship. , 1997, Revista do Instituto de Medicina Tropical de Sao Paulo.

[23]  J. Fox,et al.  Apoptosis and porcine reproductive and respiratory syndrome virus. , 2004, Veterinary immunology and immunopathology.

[24]  F. Pileggi,et al.  An in situ quantitative immunohistochemical study of cytokines and IL-2R+ in chronic human chagasic myocarditis: correlation with the presence of myocardial Trypanosoma cruzi antigens. , 1997, Clinical immunology and immunopathology.

[25]  R. Coffman,et al.  Cytokine mRNA Profile of Peripheral Blood Mononuclear Cells Isolated from Individuals with Trypanosoma cruzi Chronic Infection , 1997, Scandinavian journal of immunology.

[26]  Z. Brener (COMPARATIVE STUDIES OF DIFFERENT STRAINS OF TRYPANOSOMA CRUZI.) , 1965, Annals of tropical medicine and parasitology.

[27]  R. Gazzinelli,et al.  Chemokines, inflammation and Trypanosoma cruzi infection. , 2002, Trends in parasitology.

[28]  J. Butler A concept of humoral immunity among ruminants and an approach to its investigation. , 1981, Advances in experimental medicine and biology.

[29]  K. Gollob,et al.  IgG isotype profile is correlated with cardiomegaly in Beagle dogs infected with distinct Trypanosoma cruzi strains. , 2008, Veterinary immunology and immunopathology.

[30]  J. Guarner,et al.  Cytokine mRNA levels in the hearts of inbred mice that develop different degrees of cardiomyopathy during infection with Trypanosoma cruzi , 1998, Parasite immunology.

[31]  R. Corrêa-Oliveira,et al.  Evidence that Development of Severe Cardiomyopathy in Human Chagas' Disease Is Due to a Th1-Specific Immune Response , 2003, Infection and Immunity.

[32]  A. Rassi,et al.  Chagas' Heart Disease , 2000, Clinical cardiology.

[33]  J. Aliberti,et al.  Trypanosoma cruzi-infected cardiomyocytes produce chemokines and cytokines that trigger potent no-dependent trypanocidal , 2000 .

[34]  F. van Leuven,et al.  Increased Trypanosoma cruzi invasion and heart fibrosis associated with high transforming growth factor beta levels in mice deficient in alpha(2)-macroglobulin. , 2002, Infection and immunity.

[35]  C. Mady,et al.  Chronic Chagas' disease cardiomyopathy patients display an increased IFN-gamma response to Trypanosoma cruzi infection. , 2001, Journal of autoimmunity.

[36]  M. O. Rocha,et al.  Monocytes from Patients with Indeterminate and Cardiac Forms of Chagas' Disease Display Distinct Phenotypic and Functional Characteristics Associated with Morbidity , 2004, Infection and Immunity.

[37]  J. Galizzi,et al.  [Current clinical review of the 1st described human case of Chagas' disease]. , 1962, Revista do Instituto de Medicina Tropical de Sao Paulo.

[38]  J. C. Dias The indeterminate form of human chronic Chagas' disease A clinical epidemiological review. , 1989, Revista da Sociedade Brasileira de Medicina Tropical.

[39]  J. Epplen,et al.  Genetic and population study of a Y-linked tetranucleotide repeat DNA polymorphism with a simple non-isotopic technique , 1993, Human Genetics.

[40]  S. Reed,et al.  Interleukin 10 and interferon gamma regulation of experimental Trypanosoma cruzi infection , 1992, The Journal of experimental medicine.

[41]  R. Corrêa-Oliveira,et al.  Type 1 Chemokine Receptor Expression in Chagas' Disease Correlates with Morbidity in Cardiac Patients , 2005, Infection and Immunity.